Precision Medicine Market Size, Share, Trends & Forecast (2019 - 2025)
Precision Medicine Market is growing constantly from the decade and also to continue the same flow during the foremost time span. It is expected that the market will reach USD xx billion by 2025 and to hit a growth rate of xx% from 2019 - 2025.
Precision medicine offers better treatment by taking decisions about medicines and treatment procedures by analyzing the health records of an individual. According to the cell or molecular analysis of the patient, then they are employed to perform diagnostics tests and select appropriate therapies for the patient.
Growth Drivers
Increasing awareness of health management to have significant results without complications in the future is primarily accelerating the demand of the market. Rise in the disposable income in urbanized areas is also one of the factors influencing the growth of the market. Shifting trend towards a sedentary lifestyle is also impacting the growth of the market positively. Another factor bolstering the growth of the market rise in the number of competitors and the introduction of various drugs to cure the disease with fewer or no side effects are also ascribed to outshine the demand of the market.
Key Challenges
However, the high cost for installation and maintenance of the instruments is slightly to restrain the growth of the market. Rapid changes in economic strategies may also impact negatively on the demand of the market. Strict rules and regulations by the government are to limit the growth of the precision medicine market.
Opportunities
Rising incidences of health disorders and growing prevalence for the better treatment options are to lavish growth opportunities for the market. Increasing support from the government through funds is also leveraging the growth of the market further. The growing scale of pharmaceutical industries is also to level up the demand of the market.
What’s covered in the report?
- Overview of the global precision medicine market
- Market Drivers and challenges in the global precision medicine market.
- Market Trends in the global precision medicine market
- Historical, current and forecasted market size data for the end-use segment in the global precision medicine market (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, and healthcare IT specialists/big data companies)
- Historical, current and forecasted market size data for the therapeutics segment in the global precision medicine market (cancer, cardiovascular, central nervous system, psychiatric disorder, and infectious diseases)
- Historical, current and forecasted market size data for the sub-market segment in the global precision medicine market (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
- Analysis of the competitive landscape and profiles of major companies operating in the market
This research report includes following segmentation for the Global Precision Medicine Market:
Precision Medicine Market – By Therapeutics
- Cancer
- Cardiovascular
- Central nervous system
- Psychiatric Disorder
- Infectious Diseases
Precision Medicine Market – By Product
Based on the product, The diagnostic segment is witnessed to have a tremendous growth rate from recent years. Increasing research activities in the biotechnology field greatly prompting the demand of the market.
Precision Medicine Market – By Technology
- Big data analytics
- Bioinformatics
- Gene sequencing
- Pharmacogenomics
- Companion Diagnostics
Precision Medicine Market – By End User
- Pharmaceuticals and biotech companies
- Clinical laboratories
- Diagnostic Companies
- Healthcare IT specialists/big data companies
Precision Medicine Market - By Region
- North America
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Latin America
- Middle-East & Africa
Regionally, North America is ruling the highest shares of the market by owing to acceptance of the latest technology and launching various systems in the diagnostics segment. Increasing capital income in both developed and developing countries is also one of the factors for the market to grow in North America. The Asia Pacific and Europe are next to North America is leading the dominant shares of the market with the rise in the incidences of infectious diseases. Also, growing funds from top most companies are propelling the demand of the market in these regions. Middle East & Africa are inclined to have the highest growth rate in the coming years. Increasing incidences of various health disorders and the rise in awareness programs by the government are surging demand of the market.
Some of the players in the precision medicine market are:
- Biocrates Life Sciences,
- Tepnel Pharma Services,
- Qiagen,
- Menarini Silicon Biosystems,
- Novartis,
- NanoString Technologies,
- Pfizer,
- Eagle Genomics,
- Quest Diagnostics,
- Roche,
- Intomics,
- Teva Pharmaceutical.
Chapter 1. Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary
Chapter 2. Global precision medicine market – overview
2.1. Global market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market trends
2.4. Global market challenges
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
2.8. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
2.9. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
Chapter 3. North America precision medicine market
3.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
3.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
3.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
3.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
Chapter 4. Europe precision medicine market
4.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
4.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
4.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
4.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
Chapter 5. Asia-Pacific precision medicine market
5.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
5.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
5.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
5.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
Chapter 6. Latin America precision medicine market
6.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
6.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
6.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
6.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
Chapter 7. The Middle East and Africa precision medicine market
7.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
7.2. Market segmentation based on ecosystem players (pharmaceutical and biotechnology companies, clinical laboratories, diagnostic companies, and healthcare IT/big data companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
7.3. Market segmentation based on therapeutics (cancer, cardiovascular diseases, central nervous system [CNS] disorders, psychiatric disorders, respiratory diseases, infectious diseases, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
7.4. Market segmentation based on technology (big data analytics, bioinformatics, genomics, pharmacogenomics, companion diagnostics, epigenetics, and others) - historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), and key market observations
Chapter 8. Competitive landscape
8.1. Abbott Laboratories
8.1.a. Company snapshot
8.1.b. Products/services
8.1.c. Major initiatives/highlights
8.1.d. Growth strategy
8.1.e. Key people
8.1.f. Global presence
Note: Similar information areas will be covered for the remaining competitors:
8.2. GE Healthcare
8.3. GlaxoSmithKline
8.4. Johnson & Johnson
8.5. Pfizer
8.6. Randox Laboratories
8.7. Almac Group
8.8. Novartis AG
8.9. Teva Pharmaceutical Industries Ltd.
8.10. Quest Diagnostics
Chapter 9 Conclusion
9.1. Future outlook
Appendix
• List of tables
• Research methodology
• Assumptions
+1 888 709 8757
Chat With Us